Dexamethasone clinical trials
Also written Decadron, Hexadrol, Dexametasone and ISV-305.
Its developmentBy 30 companies, company by company92 company-led studies, furthest phase 4: when each phase was reached, its deals, target and what is ahead.Includes 66 studies of Dexamethasone phosphate, 34 studies of Dexamethasone Intravitreal Implant and 12 studies of Dexamethasone acetate.
Related medicines add 11 studies
Counted the way a researcher would: Dexamethasone with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Dexamethasone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Dexamethasone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 30 Oct 1958 · DECADRON · NDA 011664 (FDA, Drugs@FDA)
- European Union
- 26 Jul 2010 · Ozurdex · EMEA/H/C/001140 (EMA; as Dexamethasone Intravitreal Implant)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
1,787 studies that test it; most in 2021 (129); 4 more planned to start later
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1992 | 1 |
| 1993 | 2 |
| 1995 | 5 |
| 1996 | 5 |
| 1997 | 3 |
| 1998 | 10 |
| 1999 | 5 |
| 2000 | 15 |
| 2001 | 9 |
| 2002 | 25 |
| 2003 | 24 |
| 2004 | 26 |
| 2005 | 36 |
| 2006 | 42 |
| 2007 | 40 |
| 2008 | 51 |
| 2009 | 52 |
| 2010 | 57 |
| 2011 | 53 |
| 2012 | 55 |
| 2013 | 73 |
| 2014 | 79 |
| 2015 | 82 |
| 2016 | 105 |
| 2017 | 102 |
| 2018 | 103 |
| 2019 | 83 |
| 2020 | 108 |
| 2021 | 129 |
| 2022 | 78 |
| 2023 | 72 |
| 2024 | 84 |
| 2025 | 82 |
| 2026 | 90 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 197 · Other 1,600
Assiut University (42) · M.D. Anderson Cancer Center (36) · Mayo Clinic (33) · Poznan University of Medical Sciences (24) · Memorial Sloan Kettering Cancer Center (23) · Ain Shams University (21) · National Cancer Institute (NCI) (18) · Allergan (18)
Often tested with
Tested in the same studies.
Lenalidomide (170) · Bortezomib (154) · Cyclophosphamide (129) · Daratumumab (70) · Carfilzomib (69) · Pomalidomide (68) · Doxorubicin (67) · Vincristine (63)
Related medicines
As reviewed, each with the page that says it.
- One of Corticosteroids source
- One of Steroids source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 30 phase 3 studies under way
Dexamethasone is the comparator. A study of two new drugs counts under both.
- 3Elranatamab · Pfizer · next primary completion Oct 2030
- 2Ramantamig · Janssen Research & Development, LLC · next primary completion Sep 2030
- 2Linvoseltamab · Regeneron Pharmaceuticals · next primary completion Apr 2033
- 2Etentamig · AbbVie · next primary completion Feb 2033
- 2Teclistamab · University of Leeds, Janssen Research & Development, LLC · next primary completion Apr 2031
- 2Talquetamab · University of Leeds, Janssen Research & Development, LLC · next primary completion Apr 2031
- 2Daratumumab · Pfizer · next primary completion Oct 2030
- 1Odronextamab · Regeneron Pharmaceuticals · next primary completion May 2028
Reaching primary completion within a year · 114, 13 in phase 3
Studies that test Dexamethasone, phase 3 first.
- Nov 2026Comparative Efficacy Of 4 mg VS. 8 mg Submucosal Dexamethasone In Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical TrialPhase 3 · Oman Ministry of Health
- Dec 2026Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory PhenotypePhase 3 · Nantes University Hospital
- Dec 2026Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)Phase 3 · Children's Cancer Group, China
- Dec 2026First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)Phase 3 · State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
- May 2027TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in ChildrenPhase 3 · Starship Child Health, Te Toka Tumai Auckland
- Jun 2027ISTH/ANRS 0409s INTEGRATE Lassa Fever StudyPhase 2/3 · Irrua Specialist Teaching Hospital
- Aug 2027UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total TherapyPhase 3 · University of Arkansas
- Aug 2027Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma PatientsPhase 2/3 · University Hopsital Schleswig Holstein Campus Lübeck
- Sep 2027The Danish Out-of-Hospital Cardiac Arrest StudyPhase 3 · Christian Hassager
- Sep 2027Dexamethasone in Traumatic Brain InjuryPhase 3 · Assiut University
Studies
Open first, then newest update. How each study uses Dexamethasone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 1,797
- Dexamethasone Added to Transversalis Fascia Plane Block in Inguinal Hernia RepairNot yet recruitingNot applicableSivas Numune HospitalNCT07946874Written as Dexamethasone
- A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple MyelomaRecruitingPhase 1K36 Therapeutics, Inc.NCT05651932Written as Cohort A1 & A2: KTX-1001
- BrECADD Therapy in Stage 2 B-IV Hodgkin LymphomaRecruitingPhase 2University of MiamiNCT07002216Written as Dexamethasone
- Dexamethasone Doses and Glycemic Response in Diabetic CholecystectomyNot yet recruitingPhase 4Assiut UniversityNCT07942805Written as Dexamethasone 4mg
- Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/LymphomaRecruitingPhase 4St. Jude Children's Research HospitalNCT06289673Written as Dexamethasone
- Isatuximab in Combination With Novel Agents in RRMM - Master ProtocolRecruitingPhase 1/2SanofiNCT04643002Written as Dexamethasone
- Intravenous Dexamethasone for PENG Block Analgesia in Children Undergoing Hip SurgeryNot yet recruitingPhase 4Poznan University of Medical SciencesNCT07924670Written as Dexamethasone (0.1 mg/kg)
- Effect of Prophylactic Dexamethasone vs Placebo on Airway Dimensions Assessed by Ultrasonography in Patients Undergoing Laparoscopic CholecystectomyNot yet recruitingPhase 4Assiut UniversityNCT07918495Written as Dexamethasone
- Submucosal Cryotherapy and Anti-inflammatory Drugs for Postoperative Pain Following Root Canal Treatment in Maxillary MolarsNot yet recruitingPhase 3Suez Canal UniversityNCT07919938Written as Dexamethasone Sodium Phosphate
- Comparison of Spinal Anesthesia With Intrathecal Morphine Versus PENG Block With or Without Dexamethasone in Hip ArthroplastyRecruitingNot applicablePoznan University of Medical SciencesNCT07584200Written as Dexamethasone
- ACB and iPACK Blocks With Intravenous Dexamethasone and Perineural Dexmedetomidine in Total Knee ArthroplastyRecruitingNot applicablePoznan University of Medical SciencesNCT07677215Written as Dexamethasone
- Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip ArthroplastyRecruitingNot applicablePoznan University of Medical SciencesNCT07581470Written as Dexamethasone 4mg
- Dexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast CancerNot yet recruitingPhase 2Washington University School of MedicineNCT07914309Written as Dexamethasone
- Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the EDRecruitingPhase 3University of MonastirNCT06980727Written as Dexamethasone
- Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid HemorrhageRecruitingPhase 2The University of Texas Medical Branch, GalvestonNCT07294118Written as Lidocaine and Dexamethasone
- A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) AmyloidosisRecruitingPhase 2GlaxoSmithKlineNCT07224672Written as Dexamethasone
- ELEVATE-MM: Elotuzumab, Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple MyelomaRecruitingPhase 1Omar Nadeem, MDNCT06518551Written as Dexamethasone
- Dexamethasone for Ureteral STent Symptoms (DUSTS)RecruitingPhase 1/2The Methodist Hospital Research InstituteNCT06930690Written as Dexamethasone Sodium Phosphate Injection 20 mg
- A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.RecruitingPhase 2Karyopharm Therapeutics IncNCT04414475Written as Dexamethasone
- Elranatamab With Mezigdomide and Dexamethasone in Patients With Relapsed/Refractory Multiple MyelomaNot yet recruitingPhase 2PETHEMA FoundationNCT07901868Written as Dexamethasone
See all 1,797 studies that test Dexamethasone →
Given beside what is tested · 929 — Dexamethasone is usual care or a partner of the new treatment
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaRecruitingPhase 2National Cancer Institute (NCI)NCT06317662Written as Dexamethasone
- A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)RecruitingPhase 3Regeneron PharmaceuticalsNCT07222761Written as Dexamethasone
- Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM TrialRecruitingPhase 2National Cancer Institute (NCI)NCT07605416Written as Dexamethasone
- Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaRecruitingPhase 3Hoffmann-La RocheNCT07555938Written as Dexamethasone
- A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06824467Written as Dexamethasone (or equivalent)
- BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia PatientsRecruitingPhase 2Ruijin HospitalNCT07301138Written as Dexamethasone
- A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001)Not yet recruitingPhase 1Merck Sharp & Dohme LLCNCT07870278Written as Dexamethasone
- To Evaluate Safety and Efficacy of Anitocabtagene Autoleucel Versus Autologous Stem Cell Transplant in Newly Diagnosed Multiple MyelomaNot yet recruitingPhase 3Kite, A Gilead CompanyNCT07903506Written as Dexamethasone
- Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering MyelomaRecruitingPhase 3ECOG-ACRIN Cancer Research GroupNCT03937635Written as Dexamethasone
- Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE TrialRecruitingPhase 3ECOG-ACRIN Cancer Research GroupNCT04566328Written as Dexamethasone
- Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney FailureRecruitingPhase 2Eastern Cooperative Oncology GroupNCT07085728Written as Dexamethasone
- A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)RecruitingPhase 2Merck Sharp & Dohme LLCNCT07785609Written as Dexamethasone (or equivalent)
- Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06136624Written as Dexamethasone
- A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)RecruitingPhase 2Merck Sharp & Dohme LLCNCT07709000Written as Dexamethasone
- Optimal Dose of Zanubrutinib to Treat Adult Immune ThrombocytopeniaNot yet recruitingPhase 2Peking University People's HospitalNCT07315373Written as High dose dexamethasone
- A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)RecruitingPhase 2National Cancer Institute (NCI)NCT04546399Written as Dexamethasone
- TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia IIRecruitingPhase 1/2Tanja Andrea GruberNCT05848687Written as Dexamethasone
- Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple MyelomaRecruitingPhase 3PrECOG, LLC.NCT07285239Written as Dexamethasone
- Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)RecruitingPhase 1/2Novartis PharmaceuticalsNCT07387926Written as Dexamethasone
- Effect of Transversus Abdominis Plane (TAP) Block Using Magnesium Sulfate Added to Dexamethasone on Quality of Recovery and Chronic Post Operative Pain Following Open Abdominal Cancer Surgery.Not yet recruitingNot applicableAssiut UniversityNCT07928726Written as Dexamethasone
Showing 20 of 929.
As the comparator · 150 — what is tested is compared with Dexamethasone
- A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple MyelomaRecruitingPhase 3AbbVieNCT07728188Written as Dexamethasone
- Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness LevelRecruitingPhase 3University of LeedsNCT07649525Written as Dexamethasone
- A Study in Participants With Relapsed or Refractory Multiple Myeloma for QLS4131Not yet recruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT07933432Written as Dexamethasone
- MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)RecruitingPhase 3PfizerNCT06152575Written as Dexamethasone
- A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple MyelomaRecruitingPhase 3Regeneron PharmaceuticalsNCT05730036Written as Dexamethasone
- A Trial Comparing Ramantamig and Daratumumab (Ramantamig-D) Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant EligibleNot yet recruitingPhase 3Janssen Research & Development, LLCNCT07903272Written as Dexamethasone
- Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First RelapseRecruitingPhase 2National Cancer Institute (NCI)NCT06948084Written as Dexamethasone
- A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaRecruitingPhase 3Janssen Research & Development, LLCNCT05552222Written as Dexamethasone
- A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not PlannedRecruitingPhase 3Janssen Research & Development, LLCNCT07665450Written as Dexamethasone
- Study of CM336+CM313 Combination Therapy in Patients With Relapsed or Refractory Multiple MyelomaNot yet recruitingPhase 3Keymed Biosciences Co.LtdNCT07910903Written as Dexamethasone
- Effect of Temperature Elevation on the Antimicrobial Efficacy of Two Root Canal Irrigants in Primary Root Canal Infections: A Randomized Controlled Clinical TrialNot yet recruitingPhase 1/2Tanta UniversityNCT07906925Written as Dexamethasone Sodium Phosphate 10 MG/ML
- Linvoseltamab Versus Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone (Dara-Vcd) in Adult Participants With Newly Diagnosed Systemic Light Chain AmyloidosisNot yet recruitingPhase 3Regeneron PharmaceuticalsNCT07901725Written as Dexamethasone
- A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for TransplantRecruitingPhase 3PfizerNCT05623020Written as Dexamethasone
- Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After TreatmentRecruitingPhase 1/2National Cancer Institute (NCI)NCT07463807Written as Dexamethasone
- D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMMRecruitingPhase 3Dana-Farber Cancer InstituteNCT07624513Written as Dexamethasone
- Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate CancerNot yet recruitingPhase 2/3ECOG-ACRIN Cancer Research GroupNCT07852195Written as Dexamethasone
- A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)RecruitingPhase 3AstraZenecaNCT07391657Written as Dexamethasone
- Corticosteroid Lumbar Epidural Analgesia for Radicular Pain 2Not yet recruitingPhase 3Semnur Pharmaceuticals, Inc.NCT07579351Written as Dexamethasone Sodium Phosphate 10 MG/ML
- Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic CholecystectomyRecruitingPhase 4Faisalabad Medical UniversityNCT07638527Written as Dexamethasone (intravenous)
- Study to Evaluate Change in Disease Activity and Adverse Events of Subcutaneous Etentamig Compared With Daratumumab Plus Cyclophosphamide Plus Bortezomib Plus Dexamethasone (Dara-CyBorD) in Adults With Amyloid Light Chain (AL) AmyloidosisNot yet recruitingPhase 3AbbVieNCT07793422Written as Dexamethasone
Showing 20 of 150.
What changed recently
From the registry's own updates since Oct 19, 2026.
Started recruiting4
- Comparison of Spinal Anesthesia With Intrathecal Morphine Versus PENG Block With or Without Dexamethasone in Hip ArthroplastyNov 5, 2026NCT07584200
- ACB and iPACK Blocks With Intravenous Dexamethasone and Perineural Dexmedetomidine in Total Knee ArthroplastyNov 5, 2026NCT07677215
- Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the EDNov 3, 2026NCT06980727
- Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple MyelomaOct 26, 2026NCT04822337
Results posted3
- Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye DiseaseNov 10, 2026NCT04413279
- Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH TrialNov 2, 2026NCT05497804
- Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye DiseaseOct 27, 2026NCT04413253
Stopped2
- Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple MyelomaTerminatedNov 12, 2026NCT00693433
- Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With TebentafuspWithdrawnNov 6, 2026NCT07803562
Newly registered13
- Dexamethasone Added to Transversalis Fascia Plane Block in Inguinal Hernia RepairNov 18, 2026NCT07946874
- Intravenous Dexamethasone in Post Dural Puncture Headache ProphylaxisNov 18, 2026NCT07947004
- Efficacy of Perineural Dexamethasone Versus Dexmedetomidine as Adjuvants to BupivacaineNov 17, 2026NCT07941960
- Dexamethasone Doses and Glycemic Response in Diabetic CholecystectomyNov 17, 2026NCT07942805
- Intravenous Dexamethasone for PENG Block Analgesia in Children Undergoing Hip SurgeryNov 9, 2026NCT07924670
Show 8 moreShow fewer
- Effect of Prophylactic Dexamethasone vs Placebo on Airway Dimensions Assessed by Ultrasonography in Patients Undergoing Laparoscopic CholecystectomyNov 5, 2026NCT07918495
- Submucosal Cryotherapy and Anti-inflammatory Drugs for Postoperative Pain Following Root Canal Treatment in Maxillary MolarsNov 5, 2026NCT07919938
- Dexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast CancerNov 3, 2026NCT07914309
- Late Low-Dose Dexamethasone in Preterm Neonates Using DART ProtocolOct 29, 2026NCT07904104
- Elranatamab With Mezigdomide and Dexamethasone in Patients With Relapsed/Refractory Multiple MyelomaOct 28, 2026NCT07901868
- Intravenous Dexamethasone to Prolong Caudal Block Analgesia in Children Undergoing Hip SurgeryOct 26, 2026NCT07896304
- ESP Blocks in Breast Free FlapsOct 23, 2026NCT07891039
- Intravenous Dexamethasone for ESP Block Analgesia in Children Undergoing Idiopathic Scoliosis SurgeryOct 22, 2026NCT07890220
Codes
What other systems call Dexamethasone · ClinicalTrials.gg INT007323
- MeSH (NLM) D003907DexamethasoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7S5I7G3JQLDEXAMETHASONEConfirmed FDA, NLM, Wikidata
- RxNorm 3264Confirmed FDA, Wikidata
- Wikidata Q422252dexamethasoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C422DexamethasoneOne source FDA
- DrugBank DB01234One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003907 | Dexamethasone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7S5I7G3JQL | DEXAMETHASONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3264 | — | Confirmed FDA, Wikidata |
| Wikidata | Q422252 | dexamethasone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C422 | Dexamethasone | One source FDA |
| DrugBank | DB01234 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.